ReviewCureus2024

The Comparison of the Effectiveness of Dapagliflozin and Empagliflozin in the Prevention of Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Network Meta-Analysis.

Tanya Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.